Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Social Media Guides Draw Industry, User Criticism
Medical Marketing and Media
Friday, September 26, 2014 - 11:39am
tags:
FDA, social media
LabCorp Acquiring Cholesterol Tester LipoScience
Investors.com
Friday, September 26, 2014 - 11:35am
tags:
LapCorp, diagnostics, LipoScience, M&A
[video] Kite Pharma IPO Helping Fund Cancer-Drug Research: CEO
Bloomberg
Friday, September 26, 2014 - 11:32am
tags:
Kite Pharma, IPOs, cancer, R&D
Three Take-Home Messages from China's Glaxo Verdict
Forbes
Friday, September 26, 2014 - 11:04am
tags:
China, GSK
Valeant adds activist shareholder Ubben to board as Allergan takeover bid heats up
Fierce Pharma
Friday, September 26, 2014 - 10:55am
tags:
Valeant Pharmaceuticals, Allergan, M&A, Jeffrey Ubben
Fujifilm Says French Ebola Patient Taking Its Avigan Drug
Bloomberg
Friday, September 26, 2014 - 10:49am
tags:
ebola virus, Avigan, Fujifilm
AbbVie Said to Weigh More Shire Financing After U.S. Rule
Bloomberg
Friday, September 26, 2014 - 10:47am
tags:
AbbVie, Shire, tax inversions, M&A
IGI Laboratories has acquired the rights to 15 drugs from AstraZeneca's injectable business in deal worth close to $9.5 million
Bidness Etc.
Friday, September 26, 2014 - 9:14am
tags:
IGI, AstraZeneca, injectables
What Actavis Did Not Want You to See in That Antitrust Lawsuit
WSJ Pharmalot
Friday, September 26, 2014 - 9:06am
tags:
Actavis, antitrust, Alzheimer's disease, Namenda XR, Forest Labs
Pharmacyclics, Servier call it quits on a cancer drug
Fierce Biotech
Friday, September 26, 2014 - 9:05am
tags:
Pharmacyclics, Servier, Abexinostat
Gilead’s Hepatitis C Combination Wins EU Agency Backing
Bloomberg
Friday, September 26, 2014 - 9:02am
tags:
Gilead Sciences, hepatitis C, Europe, Sovaldi, ledipasvir
Gilead, Celgene Key Holdings Of Top Health Care Fund
Investors.com
Friday, September 26, 2014 - 9:01am
tags:
Gilead Sciences, Celgene
Actavis agrees to keep making original version of its Alzheimer's drug for a while
Fierce Pharma
Thursday, September 25, 2014 - 10:33pm
tags:
Actavis, Alzheimer's disease, Namenda XR
For Heart Monitor Implant, Medtronic Thinks Very Small
Bloomberg/Businessweek
Thursday, September 25, 2014 - 10:23pm
tags:
Medtronic, heart monitor, devices, Reveal LINQ
Abbott, AbbVie win dismissal of claims over Humira, AndroGel
Yahoo/Reuters
Thursday, September 25, 2014 - 10:17pm
tags:
Abbott Laboratories, AbbVie, Humira, Androgel
Allergan Declines Valeant‘s Olive Branch
Bidness Etc.
Thursday, September 25, 2014 - 10:18am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Hey, Big Pharma: When the feds swoop in, be nice. It worked for Shire
Fierce Pharma
Thursday, September 25, 2014 - 9:58am
tags:
Big Pharma, whistleblower lawsuits, False Claims Act, Shire, off-label
AbbVie May Be Next Big Loser In Tax Inversion Race
Bidness Etc.
Thursday, September 25, 2014 - 9:49am
tags:
AbbVie, tax inversions, Shire, M&A
Inovio Pharma Plans Humans Trials of Ebola Vaccine
Drug Discovery and Development
Thursday, September 25, 2014 - 9:47am
tags:
Inovio, ebola virus, vaccines
Prosensa declares progress on drug target for Duchenne
Pharmaphorum
Thursday, September 25, 2014 - 9:46am
tags:
Prosensa, Duchenne Muscular Dystrophy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.